Prothena Corp Public (PRTA) Return on Capital Employed (2013 - 2026)

Prothena Corp Public (PRTA) recorded quarterly Return on Capital Employed of 38.92% in Q1 2026, up 45.81% quarter-over-quarter from 71.82% in Q4 2025, and down 960.0% on a YoY basis from 4.53% in Q1 2025.

Prothena Corp Public (PRTA) Return on Capital Employed (2013 - 2026) Analysis & Trends

Prothena Corp Public's Return on Capital Employed history runs 14 years deep, the most recent figure standing at 38.92% for Q1 2026.

  • In Q1 2026, Return on Capital Employed fell 960.0% year-over-year to 38.92%; the TTM figure through Mar 2026 stood at 38.92% (down 960.0% YoY), while the FY2025 annual figure was 54.19%, down 2722.0% from the prior year.
  • Return on Capital Employed was 38.92% for Q1 2026 at Prothena Corp Public, up from 71.82% in the prior quarter.
  • In the past five years, Return on Capital Employed ranged from a high of 11.83% in Q1 2022 to a low of 78.71% in Q3 2025.
  • Historically, Return on Capital Employed has averaged 31.71% across 5 years, with a median of 29.3% in 2024.
  • The sharpest annual moves came in 2022 and 2025: Return on Capital Employed soared 4788 bps in 2022, then tumbled 5868 bps in 2025.
  • A 5-year view of Return on Capital Employed shows it stood at 21.71% in 2022, then tumbled by 32 bps to 28.74% in 2023, then decreased by 3 bps to 29.57% in 2024, then plunged by 143 bps to 71.82% in 2025, then jumped by 46 bps to 38.92% in 2026.
  • The last three Return on Capital Employed figures came in at 38.92% (Q1 2026), 71.82% (Q4 2025), and 78.71% (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROCE (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - 450.31%
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 51.73%
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -107.40%
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 21.10%
9 Abivax 91.96 Bn 91.96 Bn - -50.43%
10 Prothena Corp Public 479.08 Mn 149.61 Mn - -38.92%

Historic Data

Download Data
DateValue
Mar 31, 2026 -38.92%
Dec 31, 2025 -71.82%
Sep 30, 2025 -78.71%
Jun 30, 2025 -74.23%
Mar 31, 2025 -29.32%
Dec 31, 2024 -29.57%
Sep 30, 2024 -29.30%
Jun 30, 2024 -15.55%
Mar 31, 2024 -35.07%
Dec 31, 2023 -28.74%
Sep 30, 2023 -16.55%
Jun 30, 2023 -26.27%
Mar 31, 2023 -21.39%
Dec 31, 2022 -21.71%
Sep 30, 2022 -32.82%
Jun 30, 2022 -0.96%
Mar 31, 2022 11.83%
Dec 31, 2021 12.25%
Sep 30, 2021 14.79%
Jun 30, 2021 -18.39%